Show simple item record

dc.creatorKumar Singh, Awadhesh
dc.creatorSingh, Akriti
dc.creatorSingh, Ritu
dc.creatorMisra, Anoop
dc.date.accessioned2020-08-24T15:50:41Z
dc.date.available2020-08-24T15:50:41Z
dc.date.created2020
dc.identifier.issn1871-4021spa
dc.identifier.otherhttps://doi.org/10.1016/j.dsx.2020.05.017spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/12148
dc.description.abstractBackgrounds and aims: The role of hydroxychloroquine (HCQ) in the treatment of COVID-19 is not fully known. We studied the efficacy of HCQ compared to the control in COVID-19 subjects on - a. viral clearance measured by reverse transcriptase polymerase chain reaction (RT-PCR) and, b. death due to all cause. Methods: PubMed, Scopus, Cochrane and MedRxiv database were searched using the specific keywords up to April 30, 2020. Studies that met our objectives were assessed for the risk of bias applying various tools as indicated. Three studies each that reported the outcome of viral clearance by RT-PCR and death due to all cause, were meta-analyzed by applying inverse variance-weighted averages of logarithmic risk ratio (RR) using a random effects model. Heterogeneity and publication bias were assessed using the I 2 statistic and funnel plots, respectively. Results: Meta-analysis of 3 studies (n ¼ 210) on viral clearance assessed by RT-PCR showed no benefit (RR, 1.05; 95% CI, 0.79 to 1.38; p ¼ 0.74), although with a moderate heterogeneity (I2 ¼ 61.7%, p ¼ 0.07). While meta-analysis of 3 studies (n ¼ 474) showed a significant increase in death with HCQ, compared to the control (RR, 2.17; 95% 1.32 to 3.57; p ¼ 0.002), without any heterogeneity (I2 ¼ 0.0%, p ¼ 0.43). Conclusions: No benefit on viral clearance but a significant increase in mortality was observed with HCQ compared to control in patients with COVID-19.spa
dc.format.extent8 páginasspa
dc.format.mimetypeimage/jepgspa
dc.language.isoengspa
dc.publisherDiabetes & Metabolic Syndrome: Clinical Research & Reviewsspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectHydroxychloroquinespa
dc.subjectCOVID-19spa
dc.subjectViral clearancespa
dc.subjectOutcomesspa
dc.subjectDeathspa
dc.title“Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”spa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/embargoedAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAcceso restringidospa
dc.identifier.doihttps://doi.org/10.1016/j.dsx.2020.05.017spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record